Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide

Chun Che Shih, Shing Jong Lin, Kwok Hung Chung, Yuh Lien Chen, Yea Yang Su

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Current efforts of new stent technology have been aimed largely at the improvement of intravascular stent biocompatibility. Among the chemical characteristics of metallic stents, surface oxide corrosion properties are paramount. Using our unique technique, the currently marketed 316 L stainless steel and nitinol stent wires covered with polycrystalline oxide were chemically etched and then passivated to form amorphous oxide. Excellent metallicstent corrosion resistance with an amorphous oxide surface was demonstrated in our previous in vitro study. For in viva validation, we compared the corrosion behavior of different oxide surfaces on various forms of test wires in the abdominal aorta of mongrel dogs using open-circuit potential and cyclic anodic polarization measurements. After conduction, the retrieved test wires were observed under scanning electron microscope. No passivity breakdown was found for wires covered with amorphous oxide, while wires with polycrystalline oxide showed breakdown at potentials between +0.2 to + 0.6 V. It has been proven that severe pitting or crevice corrosion occurred on the surface of polycrystalline oxide, while the surface of amorphous oxide was free of degradations in our experiment. We have dermostrated that this amorphous oxide coating on metallic material provides better corrosion resistance, not only in vitro but also in vivo, and it is superior not only in strength safety but also in medical device biocompatibility. (C) 2000 John Wiley and Sons, Inc.

Original languageEnglish
Pages (from-to)323-332
Number of pages10
JournalJournal of Biomedical Materials Research
Volume52
Issue number2
DOIs
Publication statusPublished - Jan 1 2000
Externally publishedYes

Fingerprint

Stents
Oxides
Corrosion resistance
Wire
Corrosion
Biocompatibility
Anodic polarization
Stainless Steel
Pitting
Electron microscopes
Stainless steel
Scanning
Degradation
Coatings

Keywords

  • 316 L stainless steel
  • Amorphous oxide
  • Corrosion
  • Nitinol
  • Polycrystalline oxide

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering

Cite this

Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide. / Shih, Chun Che; Lin, Shing Jong; Chung, Kwok Hung; Chen, Yuh Lien; Su, Yea Yang.

In: Journal of Biomedical Materials Research, Vol. 52, No. 2, 01.01.2000, p. 323-332.

Research output: Contribution to journalArticle

@article{20e304254d024dc69f64dc73bbe7c343,
title = "Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide",
abstract = "Current efforts of new stent technology have been aimed largely at the improvement of intravascular stent biocompatibility. Among the chemical characteristics of metallic stents, surface oxide corrosion properties are paramount. Using our unique technique, the currently marketed 316 L stainless steel and nitinol stent wires covered with polycrystalline oxide were chemically etched and then passivated to form amorphous oxide. Excellent metallicstent corrosion resistance with an amorphous oxide surface was demonstrated in our previous in vitro study. For in viva validation, we compared the corrosion behavior of different oxide surfaces on various forms of test wires in the abdominal aorta of mongrel dogs using open-circuit potential and cyclic anodic polarization measurements. After conduction, the retrieved test wires were observed under scanning electron microscope. No passivity breakdown was found for wires covered with amorphous oxide, while wires with polycrystalline oxide showed breakdown at potentials between +0.2 to + 0.6 V. It has been proven that severe pitting or crevice corrosion occurred on the surface of polycrystalline oxide, while the surface of amorphous oxide was free of degradations in our experiment. We have dermostrated that this amorphous oxide coating on metallic material provides better corrosion resistance, not only in vitro but also in vivo, and it is superior not only in strength safety but also in medical device biocompatibility. (C) 2000 John Wiley and Sons, Inc.",
keywords = "316 L stainless steel, Amorphous oxide, Corrosion, Nitinol, Polycrystalline oxide",
author = "Shih, {Chun Che} and Lin, {Shing Jong} and Chung, {Kwok Hung} and Chen, {Yuh Lien} and Su, {Yea Yang}",
year = "2000",
month = "1",
day = "1",
doi = "10.1002/1097-4636(200011)52:2<323::AID-JBM11>3.0.CO;2-Z",
language = "English",
volume = "52",
pages = "323--332",
journal = "Journal of Biomedical Materials Research",
issn = "1552-4973",
publisher = "Heterocorporation",
number = "2",

}

TY - JOUR

T1 - Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide

AU - Shih, Chun Che

AU - Lin, Shing Jong

AU - Chung, Kwok Hung

AU - Chen, Yuh Lien

AU - Su, Yea Yang

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Current efforts of new stent technology have been aimed largely at the improvement of intravascular stent biocompatibility. Among the chemical characteristics of metallic stents, surface oxide corrosion properties are paramount. Using our unique technique, the currently marketed 316 L stainless steel and nitinol stent wires covered with polycrystalline oxide were chemically etched and then passivated to form amorphous oxide. Excellent metallicstent corrosion resistance with an amorphous oxide surface was demonstrated in our previous in vitro study. For in viva validation, we compared the corrosion behavior of different oxide surfaces on various forms of test wires in the abdominal aorta of mongrel dogs using open-circuit potential and cyclic anodic polarization measurements. After conduction, the retrieved test wires were observed under scanning electron microscope. No passivity breakdown was found for wires covered with amorphous oxide, while wires with polycrystalline oxide showed breakdown at potentials between +0.2 to + 0.6 V. It has been proven that severe pitting or crevice corrosion occurred on the surface of polycrystalline oxide, while the surface of amorphous oxide was free of degradations in our experiment. We have dermostrated that this amorphous oxide coating on metallic material provides better corrosion resistance, not only in vitro but also in vivo, and it is superior not only in strength safety but also in medical device biocompatibility. (C) 2000 John Wiley and Sons, Inc.

AB - Current efforts of new stent technology have been aimed largely at the improvement of intravascular stent biocompatibility. Among the chemical characteristics of metallic stents, surface oxide corrosion properties are paramount. Using our unique technique, the currently marketed 316 L stainless steel and nitinol stent wires covered with polycrystalline oxide were chemically etched and then passivated to form amorphous oxide. Excellent metallicstent corrosion resistance with an amorphous oxide surface was demonstrated in our previous in vitro study. For in viva validation, we compared the corrosion behavior of different oxide surfaces on various forms of test wires in the abdominal aorta of mongrel dogs using open-circuit potential and cyclic anodic polarization measurements. After conduction, the retrieved test wires were observed under scanning electron microscope. No passivity breakdown was found for wires covered with amorphous oxide, while wires with polycrystalline oxide showed breakdown at potentials between +0.2 to + 0.6 V. It has been proven that severe pitting or crevice corrosion occurred on the surface of polycrystalline oxide, while the surface of amorphous oxide was free of degradations in our experiment. We have dermostrated that this amorphous oxide coating on metallic material provides better corrosion resistance, not only in vitro but also in vivo, and it is superior not only in strength safety but also in medical device biocompatibility. (C) 2000 John Wiley and Sons, Inc.

KW - 316 L stainless steel

KW - Amorphous oxide

KW - Corrosion

KW - Nitinol

KW - Polycrystalline oxide

UR - http://www.scopus.com/inward/record.url?scp=0034333624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034333624&partnerID=8YFLogxK

U2 - 10.1002/1097-4636(200011)52:2<323::AID-JBM11>3.0.CO;2-Z

DO - 10.1002/1097-4636(200011)52:2<323::AID-JBM11>3.0.CO;2-Z

M3 - Article

C2 - 10951371

AN - SCOPUS:0034333624

VL - 52

SP - 323

EP - 332

JO - Journal of Biomedical Materials Research

JF - Journal of Biomedical Materials Research

SN - 1552-4973

IS - 2

ER -